Trogenix operates as a therapeutics company.
Trogenix has raised $19.1M in total funding. The most recent round was Seed. The last funding was announced in January 2024.
Trogenix's investors include IQ Capital, AIN Ventures, 4BIO Capital, Brain Tumor Investment Fund, Cancer Research Horizons.
Trogenix is headquartered in Edinburgh, United Kingdom.
Trogenix operates as a therapeutics company.
Trogenix is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Trogenix — Funding & Investors." VCBacked, January 1, 2024, https://www.vcbacked.co/company/trogenix-edinburgh-2. Accessed August 14, 2026.
VCBacked. (2024). Trogenix — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/trogenix-edinburgh-2
{{cite web |title=Trogenix — Funding & Investors |url=https://www.vcbacked.co/company/trogenix-edinburgh-2 |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated